Phase IV, Multi-center, Non-treatment, Observational, Registry Study to Determine Long Term Effects of AVONEX Therapy on EDSS, MRI, QoL, and Cognition.
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms CHAMPION CONT
- Sponsors Biogen
- 02 Aug 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 08 Jul 2010 New trial record